These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 33029523
1. EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. Xie C, Zhou M, Lin J, Wu Z, Ding S, Luo J, Zhan Z, Cai Y, Xue S, Song Y. Biomed Res Int; 2020; 2020():7804706. PubMed ID: 33029523 [Abstract] [Full Text] [Related]
2. EEF1D modulates proliferation and epithelial-mesenchymal transition in oral squamous cell carcinoma. Flores IL, Kawahara R, Miguel MC, Granato DC, Domingues RR, Macedo CC, Carnielli CM, Yokoo S, Rodrigues PC, Monteiro BV, Oliveira CE, Salmon CR, Nociti FH, Lopes MA, Santos-Silva A, Winck FV, Coletta RD, Paes Leme AF. Clin Sci (Lond); 2016 May 01; 130(10):785-99. PubMed ID: 26823560 [Abstract] [Full Text] [Related]
3. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway. Gao X, Jiang W, Ke Z, Huang Q, Chen L, Zhang G, Li C, Yu X. Biochem Biophys Res Commun; 2022 Jan 01; 586():34-41. PubMed ID: 34826698 [Abstract] [Full Text] [Related]
4. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway. Tang SL, Gao YL, Wen-Zhong H. Biomed Pharmacother; 2018 Mar 01; 99():59-64. PubMed ID: 29324313 [Abstract] [Full Text] [Related]
5. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Zhang L, Zhang W, Li Y, Alvarez A, Li Z, Wang Y, Song L, Lv D, Nakano I, Hu B, Cheng SY, Feng H. Oncogene; 2016 Oct 27; 35(43):5641-5652. PubMed ID: 27041571 [Abstract] [Full Text] [Related]
6. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S, Gonugunta VK, Penugurti V, Malisetty VL, Vadlamudi RK, Manavathi B. Cell Oncol (Dordr); 2017 Apr 27; 40(2):133-144. PubMed ID: 28039608 [Abstract] [Full Text] [Related]
8. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma. Liu PJ, Ye YX, Wang YX, Du JX, Pan YH, Fang XB. Eur Rev Med Pharmacol Sci; 2019 Aug 27; 23(15):6612-6620. PubMed ID: 31378903 [Abstract] [Full Text] [Related]
9. miR-451 suppresses EMT and metastasis in glioma cells. Nan Y, Guo L, Lu Y, Guo G, Hong R, Zhao L, Wang L, Ren B, Yu K, Zhong Y, Huang Q. Cell Cycle; 2021 Jul 27; 20(13):1270-1278. PubMed ID: 34048322 [Abstract] [Full Text] [Related]
10. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun Y, Liang XH, Wang JB, Mei QB, Zhang F, Zhang T. Cell Signal; 2016 Nov 27; 28(11):1673-82. PubMed ID: 27449264 [Abstract] [Full Text] [Related]
11. Retinol dehydrogenase 10 promotes epithelial-mesenchymal transition in spinal cord gliomas via PI3K/AKT pathway. Zhao Z, Song Z, Wang Z, Zhang F, Ding Z, Zhao Z, Liu L, Fan T. Int J Immunopathol Pharmacol; 2024 Nov 27; 38():3946320241276336. PubMed ID: 39180753 [Abstract] [Full Text] [Related]
12. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma. Song Y, Zheng S, Wang J, Long H, Fang L, Wang G, Li Z, Que T, Liu Y, Li Y, Zhang X, Fang W, Qi S. Oncotarget; 2017 Jun 27; 8(26):41947-41962. PubMed ID: 28410212 [Abstract] [Full Text] [Related]
13. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways. Chen SR, Cai WP, Dai XJ, Guo AS, Chen HP, Lin GS, Lin RS. Eur Rev Med Pharmacol Sci; 2019 Apr 27; 23(8):3461-3470. PubMed ID: 31081101 [Abstract] [Full Text] [Related]
14. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway. Liao YX, Zhang ZP, Zhao J, Liu JP. Cell Physiol Biochem; 2018 Apr 27; 48(3):1382-1396. PubMed ID: 30048971 [Abstract] [Full Text] [Related]
16. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival. Jin T, Li D, Yang T, Liu F, Kong J, Zhou Y. Oncol Rep; 2019 Aug 27; 42(2):717-725. PubMed ID: 31173266 [Abstract] [Full Text] [Related]
17. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit. Yi R, Yang S, Lin X, Zhong L, Liao Y, Hu Z, Huang T, Long H, Lin J, Wu Z, Xie C, Ding S, Luo J, Luo Q, Song Y. J Cell Mol Med; 2020 Oct 27; 24(20):11800-11813. PubMed ID: 32902145 [Abstract] [Full Text] [Related]
18. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition. Zhong C, Li X, Tao B, Peng L, Peng T, Yang X, Xia X, Chen L. Biomed Pharmacother; 2019 Aug 27; 116():109013. PubMed ID: 31146105 [Abstract] [Full Text] [Related]
19. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway. Wang L, Ren B, Zhuang H, Zhong Y, Nan Y. Technol Cancer Res Treat; 2021 Aug 27; 20():15330338211045831. PubMed ID: 34709960 [Abstract] [Full Text] [Related]
20. Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin. Xu Q, Liu Y, Wang S, Wang J, Liu L, Xu Y, Qin Y. BMC Cancer; 2022 Jun 08; 22(1):628. PubMed ID: 35672728 [Abstract] [Full Text] [Related] Page: [Next] [New Search]